Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Tasly Holding Group

2001 FOUNDED
PUBLIC STATUS
5K-10K EMPLOYEES
600535 STOCK SYMBOL
17 INVESTMENTS
$2.94 SHARE PRICE (As of Tuesday Closing)
Description

Manufacturer of pharmaceutical products created for treatment of coronary heart disease. The company's pharmaceuticals manufactured using ground-breaking technology and cutting-edge science enabling patients to relieve headache, as well as bupleurum pills, huoxiangzhengqi pills, pills for stomach diseases and andrographolide pills.

Website
Formerly Known As
Tianjin Tasly Pharmaceutical
Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Stock Exchange
SHG
Primary Office
  • Tasly Modern TCM Building No. 2
  • Pujihe East Road Beichen District
  • Tianijn, 300410
  • China

+86 00000000000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Tasly Holding Group’s full profile, request a free trial.

Tasly Holding Group Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$2.89 - $5.27 $4.58B $3.03 $0.16 7.84M 1.51B

Tasly Holding Group Financials Summary

In Thousands,
USD
TTM
30-Jun-2018
FY 2017
31-Dec-2017
FY 2016
31-Dec-2016
FY 2015
31-Dec-2015
Enterprise Value 7,219,604 7,063,790 6,909,178 7,450,953
Revenue 2,660,325 2,381,514 2,093,658 2,105,438
EBITDA 416,087 353,271 305,224 331,094
Net Income 237,555 203,692 176,618 235,446
Total Assets 3,504,360 3,298,032 2,466,412 2,374,171
Total Debt 1,462,868 1,379,320 608,342 738,826
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Tasly Holding Group Investments & Acquisitions (17)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000000 28-Aug-2018 0000 0000 Biotechnology 0000000 000
0000000 14-Aug-2018 00000 00000 00 0000 Other Devices and Supplies
000000000 00000 (0 10-Jul-2018 000000000000000000 0000 Pharmaceuticals 0000000 000
0-000 000000000 29-Jun-2018 00000 00000 00 00000 Drug Discovery 0000000 000
Shequ580 10-Jan-2018 Early Stage VC Social/Platform Software
To view this company’s complete investment and acquisition history, request access »

Tasly Holding Group Exits (5)

Company Name Exit Date Exit Type Exit Size Status Buyers
00000000 000000000 23-Mar-2017 00 000000000000000 Completed
  • 2 buyers
00000000000 000000 23-Mar-2017 00 000000000000000 00000 Completed
  • 2 buyers
00000000 03-Jan-2017 00000 00000 00 00000 Completed
  • 6 buyers
00000000 02-Sep-2015 00000 00000 00 0000 Completed
  • 3 buyers
Tianzhenshi Biotechnology Company Early Stage VC Completed
  • 3 buyers
To view this company’s complete exits history, request access »

Tasly Holding Group Subsidiaries (1)

Company Name Industry Location Founded
0000000 0000000000 Pharmaceuticals Tianjin, China 0000
To view this company’s complete subsidiary history, request access »

Tasly Holding Group Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Tasly Holding Group‘s full profile, request access.

Request full access to PitchBook

Tasly Holding Group Executive Team (1)

Name Title Board
Seat
Contact
Info
Kaijing Yan Founder, Chairman & Chief Executive Officer

Tasly Holding Group Board Members (1)

Name Representing Role Since Contact
Info
0000000 000 Tasly Holding Group Founder, Chairman & Chief Executive Officer 000 0000